New York · 2025 Regular Session · Bill
A 11301: Establishes a framework for regenerative medicine and cell-based therapies
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
A 11301 is a bill introduced in the New York House on May 11, 2026. According to its official title, it concerns: Establishes a framework for regenerative medicine and cell-based therapies. Primary sponsor: Rules Committee. Most recent recorded action (May 11, 2026): REFERRED TO HEALTH.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Establishes the "New York regenerative medicine advancement and patient protection act" to build framework for regenerative medicine and cell-based therapies; creates patient protections and disclosure requirements; authorizes limited physician use of qualifying regenerative medicine protocols; creates a regenerative medicine registry; establishes the New York regenerative medicine innovation program.
Sponsors
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Rules Committee | Primary sponsor | Not applicable (committee) | — | — |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- REFERRED TO HEALTH